Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Test Viropro's Cell-Development, Protein Technologies

NEW YORK (GenomeWeb News) — Invitrogen and Viropro have signed an R&D agreement in which Invitrogen will test protein-production techniques and cell-development technology developed by Viropro, Viropro said today.
 
Viropro, based in Montreal, also said the deal allows the company the opportunity to out-license the combined technology and make intellectual property deals with biotech companies looking to integrate the IP into their own research and production processes.
 
Jeff Greenberg, vice president of Invitrogen's BioProduction business, said the company is "enthusiastic about testing this new technology and hope to establish a long-term relationship with Viropro."

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.